FDA Device Authorizations Over the Past Decade: AI/ML, Pathway, and Specialty

from TheBrief.Health · host TheBrief.Health

Over the past decade, the U.S. Food and Drug Administration (FDA) device authorizations have shifted from incremental hardware approvals toward a flood of software-driven and artificial intelligence/machine learning (AI/ML) products that behave more like continuous services than one-time tools.

Episode metadata supplied by the publisher feed · Published May 20, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

FDA Device Authorizations Over the Past Decade: AI/ML, Pathway, and Specialty

0:00 1:48

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of TheBrief.Health?

This episode is 1 minute long.

When was this TheBrief.Health episode published?

This episode was published on May 20, 2026.

Can I download this TheBrief.Health episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!